Mai Capital Management Chroma Dex Corp. Transaction History
Mai Capital Management
- $10.1 Billion
- Q3 2024
A detailed history of Mai Capital Management transactions in Chroma Dex Corp. stock. As of the latest transaction made, Mai Capital Management holds 10,667 shares of CDXC stock, worth $56,535. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,667
Previous 12,051
11.48%
Holding current value
$56,535
Previous $32,000
18.75%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CDXC
# of Institutions
94Shares Held
17.2MCall Options Held
66.7KPut Options Held
8.2K-
Vanguard Group Inc Valley Forge, PA3.43MShares$18.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$16.5 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.96MShares$15.7 Million5.59% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$6.87 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA1.15MShares$6.09 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $362M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...